{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:52:08Z","timestamp":1740135128196,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatitis B virus (HBV) remains a major global public health problem worldwide; in endemic areas, mother-to-child transmission (MTCT) of HBV is the most common transmission route. Previous studies have shown that amniocentesis for prenatal diagnosis increases the risk of MTCT of HBV among highly viraemic mothers. However, no data is available on MTCT related fetal blood sampling (FBS) because of the paucity of cases or lack of attention. We present a case series of HBV-infected women who underwent FBS with or without antiviral therapy during pregnancy and discuss the risk of MTCT after FBS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Six hepatitis B surface antigen (HBsAg)-positive pregnant women who underwent FBS for prenatal diagnosis were retrospectively reviewed. Their infants were followed up with HBV serology parameters until at least 12\u2009months of age. Among 6 cases, two hepatitis B e-antigen (HBeAg)-positive mothers had high viral loads &gt;\u20097.0 log<jats:sub>10<\/jats:sub> IU\/mL, and one of them received antiviral therapy at 26<jats:sup>+\u20093<\/jats:sup> gestational weeks and achieved an anticipated level of 4.52 log<jats:sub>10<\/jats:sub> IU\/mL before FBS, while the other one did not receive any antiviral treatment. The other 4 cases were HBeAg-negative with low viral loads. Only a child born to the HBeAg-positive mother, who had no antiviral therapy with a viral load of 7.48 log<jats:sub>10<\/jats:sub> IU\/mL before FBS, was found to have MTCT with HBsAg persistently positive from birth to 12\u2009months of age. The other 5 children were both HBsAg-negative and HBsAb-positive at the end of follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>FBS may increase the risk of MTCT of HBV in women with HBeAg-positive and high viral loads; therefore, FBS should be avoided in this high-risk population. Maternal HBV serologic testing and awareness of the potential risk of MTCT should be recommended before FBS. Antiviral therapy may be effective to decrease the risk of MTCT after FBS in highly viraemic women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06423-x","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T02:06:24Z","timestamp":1627697184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk of mother-to-child transmission of hepatitis B virus after fetal blood sampling: a report of six cases"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhenyan","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2180-8768","authenticated-orcid":false,"given":"Hongying","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"6423_CR1","unstructured":"World Health Organization. Hepatitis B. Fact Sheets. 2020; https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"issue":"9","key":"6423_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.4254\/wjh.v7.i9.1233","volume":"7","author":"JR Lamberth","year":"2015","unstructured":"Lamberth JR, Reddy SC, Pan JJ, Dasher KJ. Chronic hepatitis B infection in pregnancy. World J Hepatol. 2015;7(9):1233\u20137. https:\/\/doi.org\/10.4254\/wjh.v7.i9.1233.","journal-title":"World J Hepatol"},{"issue":"8","key":"6423_CR3","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S1473-3099(15)00158-9","volume":"15","author":"CL Thio","year":"2015","unstructured":"Thio CL, Guo N, Xie C, Nelson KE, Ehrhardt S. Global elimination of mother-to-child transmission of hepatitis B: revisiting the current strategy. Lancet Infect Dis. 2015;15(8):981\u20135. https:\/\/doi.org\/10.1016\/S1473-3099(15)00158-9.","journal-title":"Lancet Infect Dis"},{"key":"6423_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.cgh.2018.10.007","volume":"17","author":"J Hou","year":"2019","unstructured":"Hou J, Cui F, Ding Y, Dou X, Duan Z, Han G, et al. Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus. Clin Gastroenterol Hepatol. 2019;17:1929\u20131936.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6423_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajog.2015.09.100","volume":"214","author":"J Dionne-Odom","year":"2016","unstructured":"Society for Maternal-Fetal Medicine (SMFM), Dionne-Odom J, Tita AT, Silverman NS. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol. 2016;214:6\u201314.","journal-title":"Am J Obstet Gynecol"},{"key":"6423_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.midw.2019.03.024","volume":"74","author":"HL Chen","year":"2019","unstructured":"Chen HL, Cai JY, Song YP, Zha ML, Qin G. Vaginal delivery and HBV mother to child transmission risk after immunoprophylaxis: a systematic review and a meta-analysis. Midwifery. 2019;74:116\u201325. https:\/\/doi.org\/10.1016\/j.midw.2019.03.024.","journal-title":"Midwifery."},{"issue":"1","key":"6423_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000309155","volume":"28","author":"M Lopez","year":"2010","unstructured":"Lopez M, Coll O. Chronic viral infections and invasive procedures: risk of vertical transmission and current recommendations. Fetal Diagn Ther. 2010;28(1):1\u20138. https:\/\/doi.org\/10.1159\/000309155.","journal-title":"Fetal Diagn Ther"},{"issue":"7","key":"6423_CR8","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S1701-2163(15)30546-6","volume":"36","author":"A Gagnon","year":"2014","unstructured":"Gagnon A, Davies G, Wilson RD. Prenatal invasive procedures in women with hepatitis B, hepatitis C, and\/or human immunodeficiency virus infections. J Obstet Gynaecol Can. 2014;36(7):648\u201353. https:\/\/doi.org\/10.1016\/S1701-2163(15)30546-6.","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"6423_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/uog.15945","volume":"48","author":"T Ghi","year":"2016","unstructured":"Ghi T, Sotiriadis A, Calda P, Da Silva CF, Raine-Fenning N, Alfirevic Z, et al. ISUOG practice guidelines: invasive procedures for prenatal diagnosis. Ultrasound Obstet Gynecol. 2016;48(2):256\u201368. https:\/\/doi.org\/10.1002\/uog.15945.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"6423_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jhep.2013.11.008","volume":"60","author":"W Yi","year":"2014","unstructured":"Yi W, Pan CQ, Hao J, Hu Y, Liu M, Li L, et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J Hepatol. 2014;60(3):523\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2013.11.008.","journal-title":"J Hepatol"},{"issue":"6","key":"6423_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/pd.5452","volume":"39","author":"Z Han","year":"2019","unstructured":"Han Z, Zhang Y, Bai X, Yin Y, Xu C, Hou H. Mother-to-child transmission of hepatitis B virus after amniocentesis: a retrospective matched cohort study. Prenat Diagn. 2019;39(6):431\u201340. https:\/\/doi.org\/10.1002\/pd.5452.","journal-title":"Prenat Diagn"},{"key":"6423_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ajog.2013.07.014","volume":"209","author":"SM Berry","year":"2013","unstructured":"Society for Maternal-Fetal Medicine (SMFM), Berry SM, Stone J, Norton ME, Johnson D, Berghella V. Fetal blood sampling. Am J Obstet Gynecol. 2013;209:170\u201380.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"6423_CR13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/uog.21980","volume":"56","author":"R Tanvisut","year":"2020","unstructured":"Tanvisut R, Wanapirak C, Piyamongkol W, Sirichotiyakul S, Tongprasert F, Srisupundit K, et al. Cordocentesis-associated fetal loss and risk factors: single-center experience with 6650 cases. Ultrasound Obstet Gynecol. 2020;56(5):664\u201371. https:\/\/doi.org\/10.1002\/uog.21980.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"15","key":"6423_CR14","doi-asserted-by":"publisher","first-page":"15556","DOI":"10.18632\/aging.103575","volume":"12","author":"M Cai","year":"2020","unstructured":"Cai M, Lin N, Lin Y, Huang H, Xu L. Evaluation of chromosomal abnormalities and copy number variations in late trimester pregnancy using cordocentesis. Aging (Albany NY). 2020;12(15):15556\u201365. https:\/\/doi.org\/10.18632\/aging.103575.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"6423_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijgo.2006.01.005","volume":"93","author":"C Liao","year":"2006","unstructured":"Liao C, Wei J, Li Q, Li L, Li J, Li D. Efficacy and safety of cordocentesis for prenatal diagnosis. Int J Gynaecol Obstet. 2006;93(1):13\u20137. https:\/\/doi.org\/10.1016\/j.ijgo.2006.01.005.","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"6423_CR16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/AOG.0000000000000502","volume":"124","author":"T Tongsong","year":"2014","unstructured":"Tongsong T, Wanapirak C, Piyamongkol W, Sirirchotiyakul S, Tongprasert F, Srisupundit K, et al. Second-trimester cordocentesis and the risk of small for gestational age and preterm birth. Obstet Gynecol. 2014;124(5):919\u201325. https:\/\/doi.org\/10.1097\/AOG.0000000000000502.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6423_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.14218\/JCTH.2016.00067","volume":"5","author":"MG Mavilia","year":"2017","unstructured":"Mavilia MG, Wu GY. Mechanisms and prevention of vertical transmission in chronic viral hepatitis. J Clin Transl Hepatol. 2017;5(2):119\u201329. https:\/\/doi.org\/10.14218\/JCTH.2016.00067.","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"6423_CR18","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399. https:\/\/doi.org\/10.1002\/hep.29800.","journal-title":"Hepatology."},{"issue":"1","key":"6423_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1473-3099(20)30593-4","volume":"21","author":"P Boucheron","year":"2021","unstructured":"Boucheron P, Lu Y, Yoshida K, Zhao T, Funk AL, Lunel-Fabiani F, et al. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):85\u201396. https:\/\/doi.org\/10.1016\/S1473-3099(20)30593-4.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"6423_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S1473-3099(20)30586-7","volume":"21","author":"AL Funk","year":"2021","unstructured":"Funk AL, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, et al. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):70\u201384. https:\/\/doi.org\/10.1016\/S1473-3099(20)30586-7.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"6423_CR21","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.3390\/jcm10112320","volume":"10","author":"YS Lee","year":"2021","unstructured":"Lee YS, Bang SM, Lee YS. Benefits and risks of antiviral treatment during pregnancy in patients with chronic hepatitis B. J Clin Med. 2021;10(11):2320. https:\/\/doi.org\/10.3390\/jcm10112320.","journal-title":"J Clin Med"},{"issue":"10003","key":"6423_CR22","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(15)61412-X.","journal-title":"Lancet."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06423-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06423-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06423-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T02:06:27Z","timestamp":1627697187000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06423-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6423"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06423-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Boards of the Third Affiliated Hospital of Sun Yat-sen University (approval number: [2017] 2\u2013246) and written informed consent (in Chinese) was obtained from each participant women.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent (in Chinese) was obtained from each participant women for the publication of this cases report and the accompanying information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"716"}}